Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Parasitol Res. 2012 Jul;111(1):1-6. doi: 10.1007/s00436-012-2886-x. Epub 2012 Mar 13.

    From methylene blue to chloroquine: a brief review of the development of an antimalarial therapy.

    Source

    Department of Pathology, University of Minnesota School of Medicine, Duluth, MN, USA. kristinekrafts@gmail.com

    Erratum in

    • Parasitol Res. 2012 Jul;111(1):7.

    Abstract

    Malarial treatment is widely and readily available today. However, there was a time in the not-so-distant past when malaria was a deadly disease with no known cause or cure. In this article, we trace the origins of an antimalarial therapy from the discovery of the nature of the malarial parasite through the development of chloroquine. We dedicate this article to Johann "Hans" Andersag, the scientist who developed chloroquine, on the 110th anniversary of his birth, 16 February 1902.

    PMID:
    22411634
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Springer

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk